These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6634881)

  • 1. Brain biogenic amines and pituitary-adrenocortical function in the rat.
    Maickel RP; Martel RR
    Pharmacol Biochem Behav; 1983 Aug; 19(2):321-5. PubMed ID: 6634881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacological effects and pituitary-adrenal activity.
    Marks BH; Hall MM; Bhattacharya AN
    Prog Brain Res; 1970; 32():57-70. PubMed ID: 4321530
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interrelationships between chronic restraint stress and reserpine sedation.
    Rosecrans JA; De Feo JJ
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):487-98. PubMed ID: 5895688
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of the hypothalamo-pituitary-adrenocortical axis by the central serotonergic pathway: involvement of endogenous corticotropin-releasing hormone but not vasopressin.
    Spinedi E; Gaillard RC
    J Endocrinol Invest; 1991; 14(7):551-7. PubMed ID: 1658112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of psychoactive drugs on the metabolism of intracisternally administered serotonin in rat brain.
    Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
    Biochem Pharmacol; 1969 Aug; 18(8):1971-8. PubMed ID: 5811629
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect on hypothalamo-pituitary-adrenocortical function of dopamine and norepinephrine implanted into the dorsal raphe nucleus.
    Fekete M; Hartmann G; Bódis J; Babos A; Lissák K
    Acta Physiol Acad Sci Hung; 1978; 51(3):283-91. PubMed ID: 755344
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
    Bhatnagar SP
    Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of reserpine on hypothalamo-pituitary-adrenocortical function in the rat.
    Hodges JR; Vellucci SV
    Br J Pharmacol; 1975 Apr; 53(4):555-61. PubMed ID: 167893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity and the action of reserpine on brain monoamines after pretreatment with monoamine oxidase inhibitors in isolated and aggregated mice.
    Pfeifer AK; Galambos E
    Psychopharmacologia; 1967; 11(2):130-5. PubMed ID: 5588185
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in plasma corticosterone and hypothalamic CRF levels following intraventricular injection or drug-induced changes of brain biogenic amines in the rat.
    Abe K; Hiroshige T
    Neuroendocrinology; 1974; 14(3):195-211. PubMed ID: 4368483
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of pargyline, reserpine and neurotoxin lesions on [3H]tryptamine binding sites in rat brain.
    Cascio CS; Kellar KJ
    Eur J Pharmacol; 1986 Jan; 120(1):101-5. PubMed ID: 3948908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenocortical responses of rats to acute hypoxic and hypercapnic stresses after treatment with aminergic agents.
    Marotta SF; Sithichoke N; Garcy AM; Yu M
    Neuroendocrinology; 1976; 20(2):182-92. PubMed ID: 183164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of tuberoinfundibular dopamine neurons in pargyline- and reserpine-treated rats.
    Gudelsky GA; Meltzer HY
    Neuroendocrinology; 1984 Jan; 38(1):51-5. PubMed ID: 6420718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.